Otros idiomas ReShape Lifesciences Inc.

Acciones

RSLS

US76090R2004

Mercado cerrado - Nasdaq Otros sitios de cotización 22:30:01 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,1693 ^USD	-3,42 %		-0,29 %	-32,20 %

01/04	Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024
01/04	ReShape Lifesciences Inc. informa de los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

North American Morning Briefing : Big Banks Kick -2-	12/04
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update	01/04
ReShape Lifesciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Certain Restricted Stock Units of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	30/03
Certain Warrants of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	30/03
Certain Options of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	30/03
Certain Common Stock of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	30/03
ReShape Lifesciences Gets US Patent for Intragastric Balloon Weight-Loss System	28/03
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System	28/03
ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to Intragastric Balloon System	28/03
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX	04/03
ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX	22/02
Reshape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 Flex	22/02
ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX	24/01
ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex	21/12
ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives	20/12
Wall Street op nieuwe jaarrecords gesloten	13/12
Top Midday Gainers	13/12
Wall Street in afwachting van rentebesluit	13/12
Licht hogere start voor Wall Street	13/12

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas ReShape Lifesciences Inc.

Acciones

RSLS

US76090R2004

Otros idiomas

Filtros